NEW YORK — The National Institutes of Health has awarded Phase Genomics two grants worth a combined $3.9 million. The funds will support research on sequencing-based proximity ligation (Hi-C) assays that can be used in cytogenetics.
The Small Business Innovation Research grants each provide $1.9 million over three years and will help Seattle-based Phase Genomics develop new, highly-scalable methods for detecting chromosomal rearrangements in human samples. They come from the National Human Genome Research Institute and the National Institute of Child Health and Human Development.